COVID-19 Booster and IIV Schedule in Immunocompromised Hosts | MicrobiomeTrials← Back to trialsNCT06599658
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-11-20Est. Completion: 2028-01-31
Enrollment target: 660 participants Locations- Maisonneuve -Rosemont Installation, Montreal, Quebec, Canada
- Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada
- Research Institute of McGill University Health Centre, Montreal, Quebec, Canada
Other microbiome trials you might be interested in
SARS-CoV-2
The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized a…
Coral Gables, United StatesEst. completion Jun 30, 2028
Healthy
Background:
Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease wo…
Hamilton, United StatesEst. completion Oct 31, 2033
Anogenital Herpes
COVID-19
Herpes Labialis
Background:
\- Viral infections are an important cause of illness and death in hospitalized patients as well as outpati…